SCHOTT Pharma AG & Co. KgaA

Human health matters. That is why SCHOTT Pharma designs containment solutions grounded in science to ensure that medications are safe and easy to use for people around the world. Every minute, more than 30,000 people receive an injection packed in a SCHOTT Pharma product.

The portfolio comprises drug containment solutions and delivery systems for injectable drugs ranging from prefillable glass and polymer syringes to cartridges, vials, and ampoules. Every day, a team of around 4,800 people from over 65 nations works at SCHOTT Pharma to contribute to global health.

The company is represented in all main pharmaceutical hubs with 17 manufacturing sites in Europe, North and South America, and Asia.
With over 1,000 patents and technologies developed in-house and a state-of-the-art R&D centre in Switzerland, the company is focused on developing innovations for the future.

Currently, SCHOTT Pharma has over 1,800 customers, including the top 30 leading pharma manufacturers for injectable drugs and generated revenue of €986m in the financial year 2025. SCHOTT Pharma AG & Co. KGaA is headquartered in Mainz, Germany, and listed on the Frankfurt Stock Exchange as part of the SDAX. It is majority owned by SCHOTT AG, which is owned by the Carl Zeiss Foundation. At SCHOTT Pharma, we are committed to sustainable development for society and the environment.
Further information at www.schott-pharma.com.

Whether composed of advanced polymers or glass, prefillable syringes by SCHOTT Pharma provide an optimal solution for drugs requiring a stable and secure long-term storage. These syringes also offer a safe and simple delivery method for clinicians and patients alike, allowing for easy and accurate dosing.

SCHOTT Pharma cartridges are a top choice for drug dosing, offering exceptional accuracy and compatibility with a variety of devices. Whether in emergency situations or for self-administration by diabetes patients, our cartridges provide a safe and user-friendly method for delivering drugs with precision. Robust and reliable, SCHOTT Pharma cartridges are trusted by healthcare professionals worldwide. Our cartridges are also available as RTU. Choose SCHOTT Pharma for accurate and reliable drug dosing with our high-quality cartridges.

When it comes to the safe storage of liquid drug formulations, SCHOTT Pharma vials are the optimal choice. Made of Type I Borosilicate Glass, our vials offer high chemical resistance and superior cosmetic quality, ensuring an efficient fill-and-finish process and secure container closure integrity. With accurate dimensions and a range of sizes to choose from, SCHOTT Pharma vials provide a secure and reliable storage solution for liquid drug formulations of all kinds, even as RTU. Choose SCHOTT Pharma for safe and secure storage of your liquid drug formulations with our high-quality vials.

When it comes to storing your drugs safely and reliably, choose SCHOTT Pharma's range of ampoules. Manufactured using Type I Borosilicate Glass, our ampoules offer high chemical resistance, accurate dimensions, tight cosmetic control, and drug stability from production to procedure. With a focus on quality and safety, SCHOTT Pharma's ampoules provide the optimal solution for storing and delivering drugs with confidence. Choose SCHOTT Pharma for a safe and stable storage solution for your drugs that meets the highest quality standards.

Advanced primary packaging portfolio for injectable drug products

SCHOTT Pharma’s core business is manufacturing advanced primary packaging for injectable drug products.

The portfolio consists of glass vials, glass ampoules, glass and polymer cartridges, as well as glass and polymer syringes.

All products are made to stringent quality standards using high-performance materials like Type I borosilicate glass and medical-grade cyclic olefin copolymer.

With its comprehensive service offering, SCHOTT Pharma supports the entire drug development life cycle, from research through commercialisation. The services range from developing solutions for drug containment and delivery to performing packaging-related analytical tests and optimising fill-and-finish processes, as well as providing sustainability and regulatory support.

Prefillable syringes for safe, precise, and reliable drug storage and injection

Whether made of glass or advanced polymer, SCHOTT Pharma’s prefillable syringes (PFS) offer a highly stable, long-term storage solution and a safe, convenient delivery system for patients and healthcare professionals.

By reducing the number of manual preparation steps compared to conventional packaging, PFS significantly lower the risk of medical errors and contamination, enhancing safety and reducing drug waste.

SCHOTT Pharma’s syringe portfolio is based on a versatile approach to materials, with two complementary platforms:

• syriQ® and syriQ BioPure® – made of gold-standard FIOLAX® Type I Borosilicate Glass, characterised by strong barrier properties, reliable functionality, a proven regulatory pathway, and high compatibility with a range of fill-and-finish systems.
• SCHOTT TOPPAC® – made from advanced Cyclic Olefin Copolymer (COC), characterised by its lightweight design, superior break-resistance, excellent barrier properties, and design freedom that allows customised packaging design and ensures flawless device integration.

This dual offering enables pharmaceutical companies to select the most appropriate solution based on drug formulation, delivery method, and application setting, ensuring optimal performance without compromise.

Cartridges

Pharmaceutical cartridges are cylindrical containers (for devices like pen injectors, autoinjectors and wearable devices) that enable accurate multi-dose delivery. Crafted from high-quality glass tubing or advanced polymers, SCHOTT Pharma’s cartridges are known for robust construction and exceptionally accurate dosing performance.

They fit a wide range of injection devices to ensure smooth operation and patient safety. SCHOTT Pharma provides ready-to-use cartridges under its cartriQ® brand, including specialised designs for different drug requirements.

For instance, double-chamber cartridges allow convenient reconstitution of lyophilised drugs, and break-resistant cartridges withstand high pressure or shock during use. With the SCHOTT TOPPAC® cartridge, made from highly advanced Cyclic Olefin Copolymer (COC), SCHOTT Pharma provides the first ISO-standardized ready-to-use (RTU) polymer cartridge designed for the sterile administration of highly sensitive biologics, including cell and gene therapies, biosimilars, and emergency drugs.

Vials

Glass vials are a cornerstone of SCHOTT Pharma’s product range, used to contain injectable liquids, lyophilised drugs, and vaccines. SCHOTT Pharma’s vials are made from Type I borosilicate glass, offering high chemical resistance to minimise drug-container interactions. This ensures that medications – including sensitive biologics – remain stable over shelf life without significant leachables or pH shifts.

The vials have tight dimensional tolerances and superior cosmetic quality to support efficient high-speed filling and secure container closure integrity. For example, the adaptiQ® system provides ready-to-use vials in nest-and-tub formats for streamlined fill-finish processing.

SCHOTT Pharma has also developed innovative vial solutions under its EVERIC® family to meet specialised needs. EVERIC® vials feature ultra-clean inner surfaces and other enhancements to improve drug stability and safety.

For instance, EVERIC® pure vials have a homogeneous inner glass surface for unmatched drug stability. There are also variants for specific applications under the EVERIC® concept – for example, vials for deep-frozen biologics, highly sensitive formulations, or unique identifiers to support track-and-trace of individual containers. This modular approach helps clients choose optimal vials for their needs while ensuring compatibility with standard filling lines.

Ampoules

SCHOTT Pharma produces classic glass ampoules, reflecting the company’s long heritage. Ampoules are sealed single-dose containers opened by breaking the neck. SCHOTT Pharma’s ampoules are made from Type I glass with high chemical resistance and precise dimensions, ensuring drug stability until the point of use. The company also offers safety-enhanced versions: easyOPC ampoules have a scored neck for easier, controlled opening, and Anti-Counterfeiting (AC) ampoules use unique ring markings to deter tampering and fraud.

Client support packaging services and solutions

Beyond its products, SCHOTT Pharma offers value-added services to support clients from early drug development through commercialisation. Experts assist with everything from packaging design and material selection to laboratory analytics and regulatory filings, ensuring the packaging works optimally with the drug and meets compliance requirements. The company also emphasises sustainability in packaging, collaborating with customers to reduce the carbon footprint and adopt eco-friendly practices.

SCHOTT Pharma addresses emerging industry challenges through targeted packaging solutions aligned with current trends. For example, as biologic drugs and biosimilars become more common, the company drives container innovation to maintain their stability (minimising glass delamination, protein interactions, etc.).

It has also developed solutions for mRNA vaccines and other therapies requiring low-temperature storage, ensuring containers withstand ultra-cold conditions and freeze–thaw cycles without integrity loss. To facilitate self-administration, SCHOTT Pharma provides options for delivering large-volume biologics – such as optimised polymer syringe systems – that accommodate high-viscosity drugs and enable high-speed, quality-consistent filling.

To facilitate self-administration, SCHOTT Pharma provides a broad range of options for subcutaneous large‑volume biologics — from optimised polymer syringe systems to large‑volume glass and polymer cartridges. These solutions are designed to accommodate high‑viscosity drugs while ensuring high‑speed, quality‑consistent filling.

Through continuous innovation in these areas, SCHOTT Pharma serves as a strategic partner to drug makers, helping overcome packaging hurdles as new therapies come to market.

Commitment to primary packaging quality and innovation

SCHOTT Pharma prides itself on quality and technical innovation. All products are manufactured under rigorous quality management, with state-of-the-art automation and inspection ensuring consistency.

For example, SCHOTT Pharma’s syringe lines undergo 100% camera inspection to achieve extremely low defect rates, supporting an efficient fill-and-finish process. Backed by a deep research and development (R&D) heritage, the company continually improves materials and designs – from ultra-pure vial coatings to digital traceability features. Today, SCHOTT Pharma remains at the forefront of primary packaging technology.